Biologicals

Hepatitis

Hepatitis A vaccine

Title: Requirements for hepatitis A vaccines (inactivated); Adopted 1994, TRS No 858, Annex 2

Hepatitis B vaccines, DNA recombinant

Recommendations to Assure the Quality, Safety and Efficacy of Recombinant Hepatitis B Vaccines. Proposed replacement of: TRS 786, Annex 2 and TRS 889, Annex 4.

Hepatitis B vaccine, plasma

Hepatitis WHO Working Group on Hepatitis and HIV Diagnostic Kits

Expert Committee on Biological Standardization, Geneva, 17-21 November 2003

ESSENTIAL MEDICINES AND HEALTH PRODUCTS



TSN LUNCHTIME SEMINAR

UPCOMING EVENTS


  • TCV Workshop, NIBSC, Potters Bar, UK, 8-10 March 2016
  • WHO informal consultation on labelling information on influenza vaccines intended to be used for pregnant women, Geneva, Switzerland, 4-5 April 2016
  • WHO informal consultation on WHO guidelines on regulatory preparedness for vaccine non-producing countries in response to pandemic influenza emergency, Geneva, Switzerland, 6-7 April 2016
  • WHO working group meeting on guidelines on the quality, safety and efficacy of Ebola vaccines, Geneva, Switzerland, 4-5 May 2016

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971